Zealand Pharma Aktieselskabet (OTCMKTS:ZLDPF) will be announcing its earnings results before the market opens on Thursday, May 16th.
Shares of ZLDPF opened at $19.98 on Tuesday. Zealand Pharma Aktieselskabet has a fifty-two week low of $12.10 and a fifty-two week high of $18.78.
WARNING: This story was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2019/05/14/zealand-pharma-aktieselskabet-zldpf-to-release-quarterly-earnings-on-thursday.html.
About Zealand Pharma Aktieselskabet
Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide therapeutics-based medicines in Denmark. It has a portfolio of proprietary medicines in late-stage clinical development focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide for the treatment of type 2 diabetes under the brand names of Adlyxin and Lyxumia; and a combination of lixisenatide and insulin glargine for the treatment of type 2 diabetes under the brand names of Soliqua 100/33 and Suliqua.
Featured Article: How to Profit and Limit Losses With Stop Orders
Receive News & Ratings for Zealand Pharma Aktieselskabet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zealand Pharma Aktieselskabet and related companies with MarketBeat.com's FREE daily email newsletter.